NO20064765L - Kjemisk stabile preparater av 4-hydroksytamoksifen - Google Patents

Kjemisk stabile preparater av 4-hydroksytamoksifen

Info

Publication number
NO20064765L
NO20064765L NO20064765A NO20064765A NO20064765L NO 20064765 L NO20064765 L NO 20064765L NO 20064765 A NO20064765 A NO 20064765A NO 20064765 A NO20064765 A NO 20064765A NO 20064765 L NO20064765 L NO 20064765L
Authority
NO
Norway
Prior art keywords
hydroxytamoxifen
chemically stable
preparations
stable preparations
class
Prior art date
Application number
NO20064765A
Other languages
English (en)
Other versions
NO337298B1 (no
Inventor
Dana Hilt
Valerie Masini-Eteve
Richard Fedynec
Brigitte Taravella
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of NO20064765L publication Critical patent/NO20064765L/no
Publication of NO337298B1 publication Critical patent/NO337298B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En klasse av kjemisk stabile 4-hydroksytamoksifenpreparater særpreges ved å omfatte grovt sett like mengder av Z-4-hydroksytamoksifen og E-4-hydroksytamoksifen-isomerene, slik at preparatenes aktivitet ikke på ugunstig måte påvirkes ved isomeriseringen som opptrer mellom disse to formene. Preparatene ifølge oppfinnelsen er anvendbare for å forebygge eller behandle medisinske tilstander.
NO20064765A 2004-03-22 2006-10-20 Kjemisk stabile preparater av 4-hydroksytamoksifen NO337298B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290762A EP1579857A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen
US10/805,530 US20050208139A1 (en) 2004-03-22 2004-03-22 Chemically stable compositions of 4-hydroxy tamoxifen
PCT/EP2005/003455 WO2005092310A2 (en) 2004-03-22 2005-03-18 Chemically stable compositions of 4-hydroxy tamoxifen

Publications (2)

Publication Number Publication Date
NO20064765L true NO20064765L (no) 2006-10-20
NO337298B1 NO337298B1 (no) 2016-03-07

Family

ID=34854723

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064765A NO337298B1 (no) 2004-03-22 2006-10-20 Kjemisk stabile preparater av 4-hydroksytamoksifen

Country Status (22)

Country Link
US (1) US20050208139A1 (no)
EP (4) EP1579857A1 (no)
JP (1) JP5489407B2 (no)
CN (1) CN101080222B (no)
AR (1) AR048587A1 (no)
AT (1) ATE453387T1 (no)
AU (1) AU2005227073B2 (no)
CA (1) CA2557806C (no)
DE (1) DE602005018613D1 (no)
DK (1) DK1727532T3 (no)
ES (3) ES2402921T3 (no)
HK (2) HK1098674A1 (no)
IL (2) IL177778A (no)
MX (1) MXPA06010928A (no)
NO (1) NO337298B1 (no)
NZ (1) NZ549664A (no)
PL (1) PL1727532T3 (no)
PT (1) PT1727532E (no)
RU (1) RU2389483C2 (no)
TW (1) TWI401078B (no)
WO (1) WO2005092310A2 (no)
ZA (1) ZA200607291B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2050443B1 (en) * 2002-12-18 2017-05-24 Besins Healthcare Luxembourg SARL Reduction of breast density with 4-hydroxy tamoxifen
EP1572178B1 (en) * 2002-12-18 2006-05-03 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
US7704516B2 (en) 2003-04-01 2010-04-27 Laboratories Besins International Sa Percutaneous composition comprising 4-hydroxy tamoxifen
AU2004246812B8 (en) * 2003-06-09 2010-01-14 Besins Healthcare Luxembourg Sarl Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
DE602005011314D1 (de) * 2004-10-14 2009-01-08 Besins Int Lab 4-hydroxytamoxifengel-formulierungen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
CA2775266C (en) 2009-10-13 2013-12-31 Duquesne University Of The Holy Spirit, A Nonprofit Corporation Organized Under The Laws Of The Commonwealth Of Pennsylvania Anti-cancer tamoxifen-melatonin hybrid ligand
WO2013010137A2 (en) * 2011-07-14 2013-01-17 Jacks Health Technologies Llc A composition, device and method for delayed and sustained release of brain energy molecules

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
US5475851A (en) * 1986-04-14 1995-12-12 National Instruments Corporation Method and apparatus for improved local and global variable capabilities in a graphical data flow program
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
CA2032695A1 (en) 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US6160549A (en) * 1994-07-29 2000-12-12 Oracle Corporation Method and apparatus for generating reports using declarative tools
DE4435784C2 (de) * 1994-10-06 1998-10-29 Heraeus Electro Nite Int Elektrisch beheizbarer Starterkat
US5777621A (en) * 1994-12-22 1998-07-07 Apple Computer, Inc. Quality control mechanism for three-dimensional graphics rendering
AU725286B2 (en) * 1996-01-20 2000-10-12 Bradford University Tamoxifen and analogues thereof
JP2001500841A (ja) * 1996-03-29 2001-01-23 エス ヴェー パテントフェアヴェアツングス ゲゼルシャフト ミット ベシュレンクテル ハフツンク 障害された皮下結合脂肪組織、とりわけ脂肪性浮腫の場合における皮膚を引きしめ滑らかにするための化粧品および化粧用組成物
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
EP1043986B1 (en) * 1997-12-23 2003-04-16 Hexal Ag Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
JP2000038335A (ja) * 1998-07-22 2000-02-08 Kanebo Ltd 皮膚化粧料
EP1212325A2 (en) 1999-08-23 2002-06-12 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2002340120A1 (en) * 2001-10-04 2003-04-14 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
EP1317921B1 (fr) * 2001-12-07 2009-08-19 Besins International Belgique Composition pharmaceutique sous forme de gel ou de solution à base de dihydrotestostérone, son procédé de préparation et ses utilisations
US6695171B2 (en) * 2002-02-12 2004-02-24 Seaquistperfect Dispensing Foreign, Inc. Pump dispenser
EP1572178B1 (en) * 2002-12-18 2006-05-03 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
EP2050443B1 (en) * 2002-12-18 2017-05-24 Besins Healthcare Luxembourg SARL Reduction of breast density with 4-hydroxy tamoxifen
US7704516B2 (en) * 2003-04-01 2010-04-27 Laboratories Besins International Sa Percutaneous composition comprising 4-hydroxy tamoxifen
AU2004246812B8 (en) * 2003-06-09 2010-01-14 Besins Healthcare Luxembourg Sarl Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
ATE401067T1 (de) * 2003-12-15 2008-08-15 Besins Int Lab Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations

Also Published As

Publication number Publication date
TW200533334A (en) 2005-10-16
EP1727532B1 (en) 2009-12-30
IL215897A0 (en) 2011-12-29
WO2005092310A3 (en) 2005-12-01
AU2005227073B2 (en) 2011-06-23
HK1139332A1 (en) 2010-09-17
NO337298B1 (no) 2016-03-07
MXPA06010928A (es) 2006-12-15
ZA200607291B (en) 2008-04-30
CA2557806C (en) 2011-08-30
ES2337069T3 (es) 2010-04-20
EP2147670B1 (en) 2014-10-01
EP2269599A1 (en) 2011-01-05
RU2006137282A (ru) 2008-04-27
CA2557806A1 (en) 2005-10-06
HK1098674A1 (en) 2007-07-27
ES2402921T3 (es) 2013-05-10
PL1727532T3 (pl) 2010-06-30
EP2269599B1 (en) 2013-02-20
EP2147670A1 (en) 2010-01-27
CN101080222A (zh) 2007-11-28
WO2005092310A2 (en) 2005-10-06
IL215897A (en) 2014-09-30
EP1727532A2 (en) 2006-12-06
JP2007530498A (ja) 2007-11-01
TWI401078B (zh) 2013-07-11
IL177778A (en) 2011-12-29
ATE453387T1 (de) 2010-01-15
AU2005227073A1 (en) 2005-10-06
CN101080222B (zh) 2013-08-07
AR048587A1 (es) 2006-05-10
US20050208139A1 (en) 2005-09-22
IL177778A0 (en) 2006-12-31
DK1727532T3 (da) 2010-05-03
EP1579857A1 (en) 2005-09-28
RU2389483C2 (ru) 2010-05-20
NZ549664A (en) 2011-01-28
JP5489407B2 (ja) 2014-05-14
DE602005018613D1 (de) 2010-02-11
PT1727532E (pt) 2010-03-30
ES2517894T3 (es) 2014-11-04

Similar Documents

Publication Publication Date Title
NO20064765L (no) Kjemisk stabile preparater av 4-hydroksytamoksifen
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
NO20065984L (no) Forbindelser og sammensetninger som PPAR modulatorer
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
TW200720269A (en) Apoptosis promoters
NO20065983L (no) Forbindelser og sammensetninger som PPAR modulatorer
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
NO20081042L (no) PPAR aktive forbindelser
NO20073068L (no) Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
NO20074238L (no) Fiksert dosering av HER-antistoffer
NO20052028L (no) Pyridinderivater som CB2 reseptor modulatorer
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
NO20080217L (no) B-celle reduksjon ved anvendelse av CD20-spesifikke bindingsmolekyler
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
WO2006084176A3 (en) Compounds and compositions as ppar modulators
NO20061074L (no) Forbindelser og sammensetninger som inbibitorer av reseptortyrosinkinaseaktivitet
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20045429L (no) Kombinasjon av organiske forbindelser
TW200602330A (en) Compounds and compositions as PPAR modulators
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: LAB BESINS INTERNATIONAL, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL, LU